Form 8-K - Current report:
SEC Accession No. 0001193125-25-125484
Filing Date
2025-05-23
Accepted
2025-05-23 08:00:23
Documents
12
Period of Report
2025-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d13190d8k.htm   iXBRL 8-K 33274
  Complete submission text file 0001193125-25-125484.txt   151212

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA snse-20250521.xsd EX-101.SCH 2845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20250521_lab.xml EX-101.LAB 18738
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20250521_pre.xml EX-101.PRE 11704
14 EXTRACTED XBRL INSTANCE DOCUMENT d13190d8k_htm.xml XML 3745
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 25979317
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)